P
PeterLabs Holdings Bhd
KLSE:PLABS
PeterLabs Holdings Bhd
KLSE:PLABS
Price:
0.27
MYR
Market Closed
Market Cap:
74.3m
MYR
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
MY |
|
Frenkel Topping Group PLC
LSE:FEN
|
UK |
|
Cadence Minerals PLC
LSE:KDNC
|
UK |
|
Pet Valu Holdings Ltd
TSX:PET
|
CA |
|
Genex Power Ltd
ASX:GNX
|
AU |
|
T
|
TeamViewer SE
F:TMV1
|
DE |
|
Intikeramik Alamasri Industri Tbk PT
IDX:IKAI
|
ID |
|
M
|
Mobirix Corp
KOSDAQ:348030
|
KR |
Multiples-Based Value
The Multiples-Based Value of one PLABS stock under the Base Case scenario is hidden MYR. Compared to the current market price of 0.27 MYR, PeterLabs Holdings Bhd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PLABS Multiples-Based Value
LOCKED
Multiples Across Competitors
PLABS Competitors Multiples
PeterLabs Holdings Bhd Competitors
PeterLabs Holdings Bhd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| MY |
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
74.3m MYR | 0.6 | 475.4 | 420.3 | 420.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.6B CHF | 5.3 | 21.2 | 13.1 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
221.8B GBP | 5.2 | 29.6 | 16.4 | 23.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.4 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
